Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Personalized Medicine for Lung Cancer

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
159 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 28, 2011

Dr. William Pao, director of the division of hematology and oncology at Vanderbilt-Ingram Cancer Center, explains what personalized cancer medicine means for the future of lung cancer treatment. You can also see Dr. Pao on December 14 from 1:30-2 p.m. CST during a live video chat as he and Dr. Mia Levy discuss DNA-driven cancer care. Learn more and register for the live chat: http://www.MyHealthChat.com

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • National Cancer Institute : The cost of cancer in 2020 in the U.S. is projected to reach at least $158 billion (in 2010 dollars). Assuming a 2 percent annual increase in medical costs in the initial and final phases of care, the projected 2020 costs increase to $173 billion. Estimating a 5 percent annual increase in these costs raises the projection to $207 billion. These figures do not include other types of costs, such as lost productivity, which add to the overall financial burden of cancer.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more